Healthcare Services company Dr. Lal Pathlabs announced Q1FY25 results: Revenue increased by 11.3% in Q1FY25 to Rs 602 crore EBITDA increased by 16.2% with a margin of 28.2% PAT increased by 29.1% to Rs 108 crore with a margin for of 17.9% Interim Dividend of Rs 6 per share for FY 2024-25 Result PDF
Conference Call with Dr. Lal Pathlabs Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Dr. Lal PathLabs announced Q4FY24 results: Revenue increased by 11.1% in Q4FY24 EBITDA increased by 25.1% with a margin of 26.5% PAT increased by 50.8% with a margin for of 15.7% Result PDF